These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1784589)

  • 41. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.
    Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S
    Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells.
    Ferry RC; Unsworth CD; Molinoff PB
    Mol Pharmacol; 1993 May; 43(5):726-33. PubMed ID: 8388988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 5-HT2 receptor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis.
    Sorensen SM; Humphreys TM; Taylor VL; Schmidt CJ
    J Pharmacol Exp Ther; 1992 Feb; 260(2):872-8. PubMed ID: 1531362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serotonin receptors in the rat nucleus tractus solitarii and cardiovascular regulation.
    Shvaloff A; Laguzzi R
    Eur J Pharmacol; 1986 Dec; 132(2-3):283-8. PubMed ID: 3102261
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of fenfluramine and para-chloroamphetamine on sexual behavior of male rats.
    Foreman MM; Hall JL; Love RL
    Psychopharmacology (Berl); 1992; 107(2-3):327-30. PubMed ID: 1615133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo.
    Done CJ; Sharp T
    Br J Pharmacol; 1992 Sep; 107(1):240-5. PubMed ID: 1422575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. alpha2-Adrenoceptor antagonists reverse the 5-HT2 receptor antagonist suppression of head-twitch behavior in mice.
    Matsumoto K; Mizowaki M; Thongpraditchote S; Murakami Y; Watanabe H
    Pharmacol Biochem Behav; 1997 Mar; 56(3):417-22. PubMed ID: 9077577
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The head-twitch response in the least shrew (Cryptotis parva) is a 5-HT2- and not a 5-HT1C-mediated phenomenon.
    Darmani NA; Mock OB; Towns LC; Gerdes CF
    Pharmacol Biochem Behav; 1994 Jun; 48(2):383-96. PubMed ID: 8090805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M; Lyon RA; Davis KH; Glennon RA
    Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serotonin 5-HT2c agonists mimic the effect of light pulses on circadian rhythms.
    Kennaway DJ; Moyer RW
    Brain Res; 1998 Sep; 806(2):257-70. PubMed ID: 9739147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic treatment with (+/-)DOI, a psychotomimetic 5-HT2 agonist, downregulates 5-HT2 receptors in rat brain.
    McKenna DJ; Nazarali AJ; Himeno A; Saavedra JM
    Neuropsychopharmacology; 1989 Mar; 2(1):81-7. PubMed ID: 2803482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms involved in the hyperglycemic effect of the 5-HT1C/5-HT2 receptor agonist, DOI.
    Baudrie V; Chaouloff F
    Eur J Pharmacol; 1992 Mar; 213(1):41-6. PubMed ID: 1499656
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Naloxone and serotonin receptor subtype antagonists: interactive effects upon deprivation-induced intake.
    Beczkowska IW; Bodnar RJ
    Pharmacol Biochem Behav; 1991 Mar; 38(3):605-10. PubMed ID: 1906186
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of long-term treatment with the 5-HT1A receptor agonist 8-OH-DPAT and the 5-HT2/1C receptor agonist DOI in the neonatal rat.
    Johansson-Wallsten CE; Berg M; Meyerson BJ
    Eur J Pharmacol; 1993 Oct; 243(2):149-54. PubMed ID: 8276064
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mediation of ACTH and prolactin responses to 5-HTP by 5-HT2 receptors.
    Gartside SE; Cowen PJ
    Eur J Pharmacol; 1990 Apr; 179(1-2):103-9. PubMed ID: 2163847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mescaline: excitatory effects on acoustic startle are blocked by serotonin2 antagonists.
    Davis M
    Psychopharmacology (Berl); 1987; 93(3):286-91. PubMed ID: 3124159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations.
    Costall B; Naylor RJ
    Br J Pharmacol; 1995 Dec; 116(7):2989-99. PubMed ID: 8680734
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of 5HT2 receptor blockade on the startle reflex and its prepulse inhibition in mice and rats of various strains].
    Popova NK; Barykina NN; Alekhina TA; Naumenko KS; Kulikov AV
    Ross Fiziol Zh Im I M Sechenova; 1999 Jun; 85(6):857-64. PubMed ID: 10512006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Action of serotonin in the medial prefrontal cortex: mediation by serotonin3-like receptors.
    Ashby CR; Edwards E; Wang RY
    Synapse; 1992 Jan; 10(1):7-15. PubMed ID: 1536032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of 5-HT2 receptor antagonists on a cranial nerve reflex in the rabbit: evidence for inverse agonism.
    Harvey JA; Welsh SE; Hood H; Romano AG
    Psychopharmacology (Berl); 1999 Jan; 141(2):162-8. PubMed ID: 9952040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.